Insulin aspart, recombinant Subcutaneous and Retrovir (Zidovudine Syrup)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Retrovir (Zidovudine Syrup) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zidovudine
Brand name: Retrovir
Synonyms: Retrovir (oral/injection), Retrovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Retrovir Infusion
- Insulin aspart, recombinant Subcutaneous-Retrovir Intravenous
- Insulin aspart, recombinant Subcutaneous-Retrovir oral/injection
- Insulin aspart, recombinant Subcutaneous-Revatio
- Insulin aspart, recombinant Subcutaneous-Revatio Injection
- Insulin aspart, recombinant Subcutaneous-Revatio Intravenous
- Retrovir (Zidovudine Syrup)-Insulin degludec
- Retrovir (Zidovudine Syrup)-Insulin Degludec (U-100) Prefilled Pens
- Retrovir (Zidovudine Syrup)-Insulin Degludec (U-100) Vials
- Retrovir (Zidovudine Syrup)-Insulin Degludec (U-200) Prefilled Pens
- Retrovir (Zidovudine Syrup)-Insulin degludec and liraglutide
- Retrovir (Zidovudine Syrup)-Insulin degludec and liraglutide Subcutaneous